Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · iRhythm Holdings, Inc. (IRTC)

iRhythm Completes $237.5 Million Acquisition of VitalConnect, Adding Cardiac Monitoring Capabilities

Neutral Impact 3 of 5 m&a Written later

iRhythm Holdings said on October 5, 2026 that it completed its previously announced acquisition of VitalConnect, a maker of wearable biosensor technology for ambulatory cardiac monitoring. The company says the deal broadens its portfolio and addressable market and is expected to enhance its revenue growth rate beginning in 2027 while preserving its 15% adjusted EBITDA margin target for 2027.

Key points

  • Purchase consideration was $237.5 million in cash, subject to customary adjustments, funded from iRhythm's balance sheet, plus up to 423,334 shares issued at closing.
  • iRhythm provided $10.0 million of working capital funding to VitalConnect between signing and closing.
  • iRhythm will provide updated 2026 financial guidance, inclusive of VitalConnect, on its third quarter earnings call on November 5, 2026.

The filing

CompanyiRhythm Holdings, Inc. (IRTC)
Form8-K, current report
Filed with the SECOct 5, 2026, 9:07 AM ET
Accession number0001388658-26-000083

Items reported: 7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 10:08 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 05, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.